Study on Type of Stroke with Special Preference to Association of Modifiable Risk Factors in Kosi Zone
DOI:
https://doi.org/10.21276/xpwd8z70Keywords:
Stroke, Modifiable Risk Factors, HypertensionAbstract
Background: Stroke is a global health problem and the second most common cause of death. It also entails a high socioeconomic burden due to increased mortality and morbidity. Despite substantial advances for treatment of stroke, effective primary stroke prevention remains the best means for reducing stroke burden.
Methods: It was a cross-sectional study including 100 cerebrovascular patients and hundred non-cerebrovascular accident controls(age-sex matched) who were studied to determine the incidence of various types of stroke and association of various modifiable risk factors with stroke.
Results: Incidence of ischaemic stroke was more than haemorrhagic stroke. Also, strong correlation exists between smoking, hypertension, diabetes, dyslipidemia and stroke.
Conclusions: Effective management of these common risk factors can reduce the incidence, mortality and morbidity associated with stroke. Hence, primary prevention of stroke is of immense public health importance.
Downloads
References
M. Gold stein (Chairman) USA, HJM Barnett Canada, J.M. Orgogozo France et al Stroke, Recommendations on stroke prevention, diagnosis and therapy: report WHO task force on stroke and other cerebrovascular disordersa. Stroke 1989,20(10):1407-1431
Journal of Stroke, Jeyaraj Durai Pandian, Paulin Sudhan 2013,15(3) 128-134
Feigin V, Lawes C, Bennet D, Barker_Cellos, Parag V., Worldwide Stroke incidence and early case fatality in 56 Population based studies, a systematic review. Lancet neurology 2009,8(4) 355-369
Gupta R., Joshi P, Mohan V, Reddy S, Yusuf S, Epidemiology and causation of coronary heart disease and stroke in India, Heart 2008:94, 16-26
Golstein L, et al, Circulation 2001,103. 163-182
Broderick J et al stroke 1998,29:415-429
Brown WV. Clin Cornerstone 2004: 6( supple 3) s30-s34
Gorelick PB. Stroke prevention. Arch Neurol. 1995;52:347–355.
Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR,Mosca L, Sacco RL, Sherman DG, Wolf PA, delzoppo GJ. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke.2001;32:280 –299.
Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr, Smith S Jr, Stone NJ, Taubert KA. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003;107:645– 651.
American Heart Association. Heart Disease and Stroke Statistics—2004 Update. Dallas, Tex: American Heart Association; 2003.
Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415– 421.
Rosamond WD, Folsom AR, Chambless LE, Wang CH, mcgovern PG, Howard G, Copper LS, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736 –743.
Amarenco P. Hypercholesterolemia, lipid lowering agents, and risk for brain infarction. Neurology 2001;57 (supplement 2); 35-44.
Briel M, Studer M, Glass TR, Bucher HC(2004). Effects of statins on stroke prevention in patients with or withour coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 117(8); 596-606.
Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke. 2001;32:1793–1799.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–8. [pubmed: 1866765]
Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation:How well do randomized trials translate into clinical practice? JAMA 2003;290:2685–92. [pubmed:14645310]
Autret A, Pourcelot L, Saudeau D, et al. Stroke risk in patients with carotid stenosis. Lancet 1987;1:888–90. [pubmed: 2882292]
Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986;315:860–5. [pubmed: 3528855]
Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281:53–60. [pubmed: 9892451]
Caplan LR , Dyken ML, Easton JD. American Heart Association Family Guide to Stroke. New York, Random House, 1994;63
Shinton R, Sagar G. Lifelong exercise and stroke. BMJ 1993;307:231–4. [pubmed: 8369683] [published correction appears in BMJ. 1993;307:706]
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
